CD4 and breast carcinoma: Similarly, it also showed that antitumor immune cells such as B cells, CD8+ T cells, CD4+ effector T cells and dendritic cells were enriched in Th2-low group based on TCGA breast cancer database (Additional file 1: Fig. S1A).